Atopic dermatitis, vitiligo, systemic sclerosis-related interstitial lung disease Vitiligo is an autoimmune skin disorder with a global prevalence of 12%
Drugs with glucagon-like peptide-1 receptor agonist (arGLP-1) action for overweight/obesity, such as liraglutide, semaglutide, and tirzepatide, have shown improvements in weight and body composition, as well as in parameters related to glucose metabolism, hypertension, dyslipidemia (reduction of triglycerides and increase in HDL cholesterol), and metabolic dysfunction-associated steatotic liver disease
Redness, itching, or swelling at the injection site occurs with both peptides but is typically mild and self-resolving
The truth is, your farts, smelly or otherwise, are far more than just an embarrassing bodily function